Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1997Journal of Clinical Oncology

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

View Full Paper
Ask AI
Bookmark
Share

Authors

MPMichael F. PressUniversity of Southern California
Leslie Bernstein
Leslie BernsteinBroad InstitutePTP. ThomasRutgers, The State University of New Jersey

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Press et al. (1997) studied this question.

synapsesocial.com/papers/6a0cd465c031bbff4134c4cdhttps://doi.org/10.1200/jco.1997.15.8.2894
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.1992 · 458 citations
  2. 2Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.1992 · 843 citations
  3. 3How To Use Prognostic Factors in Axillary Node-Negative Breast Cancer Patients1990 · 320 citations
  4. 4ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.1992 · 563 citations
  5. 5Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group.1993 · 537 citations